E-cigarette Use for Smokers with Mental Illness
Trial Summary
What is the purpose of this trial?
This study aims to establish the feasibility and acceptability of a project designed to investigate the impact of electronic cigarette use on combustible cigarette smoking and smoking-related factors among smokers with psychiatric disorders, a high-risk population, who are not yet ready to quit smoking. All participants will be instructed to switch completely from combustible cigarettes to e-cigarettes for the next 8 weeks. They will be assessed at baseline, 2 weeks, 4 weeks, 8 weeks and 12 weeks.
Research Team
Haruka Minami, Ph.D.
Principal Investigator
Fordham University
Eligibility Criteria
This trial is for English-speaking adults over 21 with a psychiatric disorder who smoke at least 5 cigarettes daily and have been doing so for over 6 months. Participants should not be currently trying to quit smoking, using quitting aids, or have cognitive impairments that prevent informed consent. They must not be pregnant, breastfeeding, planning pregnancy soon, or have unstable heart or lung conditions.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- E-cigarette (Other)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Fordham University
Lead Sponsor
Montefiore Medical Center
Collaborator
Andrew D. Racine
Montefiore Medical Center
Chief Medical Officer since 1992
MD, PhD from New York University; Undergraduate degree from Harvard University
Philip O. Ozuah
Montefiore Medical Center
Chief Executive Officer since 2019
MD, PhD from New York University
Dartmouth College
Collaborator
Sian Leah Beilock
Dartmouth College
Chief Executive Officer since 2023
PhD in Cognitive Psychology and Neuroscience from Miami University
Estevan Garcia
Dartmouth College
Chief Medical Officer since 2024
MD from Stony Brook University School of Medicine